Narrow search
Showing 1 - 10 of 252
Cover Image
Five-Year Evolution of Drug Prescribing in a University Adult Intensive Care Unit
Carron, Christine; Voirol, Pierre; Eggimann, Philippe; … - In: Applied Health Economics and Health Policy 10 (2012) 5, pp. 355-358
Persistent link: https://www.econbiz.de/10011005058
Cover Image
PleurX Peritoneal Catheter Drainage System for Vacuum-Assisted Drainage of Treatment-Resistant, Recurrent Malignant Ascites: A NICE Medical Technology Guidance
White, Judith; Carolan-Rees, Grace - In: Applied Health Economics and Health Policy 10 (2012) 5, pp. 299-308
. Positive patient opinions relating to improved symptom control and convenience were reported in a qualitative study. Cost …
Persistent link: https://www.econbiz.de/10011005059
Cover Image
Cost Effectiveness of Drug-Eluting Stents in Acute Myocardial Infarction Patients in Germany: Results from Administrative Data Using a Propensity Score-Matching Approach
Baumler, Michael Bumler; Stargardt, Tom; Schreyogg, … - In: Applied Health Economics and Health Policy 10 (2012) 4, pp. 235-248
drug-eluting stents (DES) and bare-metal stents (BMS) have not shown clear evidence that one intervention is more cost … effective than the other. Abstract: Objective:Objective: The aim of this study was to measure the cost effectiveness of DES … and 2005 were followed up for 1 year after hospital discharge. The cost of treatment and survival after 365 days were …
Persistent link: https://www.econbiz.de/10011005060
Cover Image
Cost Effectiveness of Prostacyclins in Pulmonary Arterial Hypertension
Roman, Antonio; Barberà, Joan A. Barber; Escribano, Pilar - In: Applied Health Economics and Health Policy 10 (2012) 3, pp. 175-188
profile and economic aspects. Abstract: Objective:Objective: This study provides a cost-effectiveness and cost … treprostinil (2.69 LYG and 1.73 QALY). Incremental cost-effectiveness ratios (ICER) and cost-utility ratios (ICUR) of epoprostenol … dominant strategy in 15% of the simulations, but it was not a cost-effective option in 83% of the cases. When compared with …
Persistent link: https://www.econbiz.de/10011005061
Cover Image
An Application of a Proposed Framework for Formulary Listing in Low-Income Countries: The Case of Côte d'Ivoire
Diaby, Vakaramoko; Lachaine, Jean - In: Applied Health Economics and Health Policy 9 (2011) 6, pp. 389-402
'Ivoire considered severity of disease and cost effectiveness of treatment to be the most significant criteria for priority reimbursement … (cost per patient). This selection would start from the first treatment, going down the list until the $US66 per …
Persistent link: https://www.econbiz.de/10011005062
Cover Image
Cost-Effectiveness Analysis of Early versus Non-Early Intervention in Acute Migraine Based on Evidence from the 'Act when Mild' Study
Slof, John - In: Applied Health Economics and Health Policy 10 (2012) 3, pp. 201-215
the attack to develop to a higher pain intensity level. Abstract: Objective:Objective: To investigate the cost …-early treatment of acute migraine with almotriptan. Incremental cost-effectiveness ratios (ICERs) were determined in terms of QALYs … cost-effectiveness acceptability curves. Abstract: Results:Results: Early treatment has shown to lead to shorter attack …
Persistent link: https://www.econbiz.de/10011005063
Cover Image
The Chinese Healthcare System: Structure, Problems and Challenges
Hougaard, Jens Leth.; Østerdal, Lars Peter. sterdal; Yu, Yi - In: Applied Health Economics and Health Policy 9 (2011) 1, pp. 1-13
We describe the structure and present situation of the Chinese healthcare system and discuss its primary problems and challenges. We discuss problems with inefficient burden sharing, adverse provider incentives and huge inequities, and seek explanations in the structural features of the Chinese...
Persistent link: https://www.econbiz.de/10011005064
Cover Image
Insensitivity to Scope in Contingent Valuation Studies: Reason for Dismissal of Valuations?
Søgaard, Rikke Sgaard; Lindholt, Jes; Gyrd-Hansen, Dorte - In: Applied Health Economics and Health Policy 10 (2012) 6, pp. 397-405
Background:Background: The credibility of contingent valuation studies has been questioned because of the potential occurrence of scope insensitivity, i.e. that respondents do not react to higher quantities or qualities of a good. Abstract: Objective:Objective: The aim of this study was to...
Persistent link: https://www.econbiz.de/10011005065
Cover Image
Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain: The ECOBIM Study
Dilla, Tatiana; Valladares, Amparo; Nicolay, Claudia; … - In: Applied Health Economics and Health Policy 10 (2012) 6, pp. 417-430
-BMI gainers). One-unit gain (or loss) in BMI was significantly (p < 0.001) associated with a 2.4% cost increase (or decrease … benefit associated with reducing one BMI unit was 9.4% cost decrease in obese and 2.7% in non-obese patients (4-slope model …
Persistent link: https://www.econbiz.de/10011005066
Cover Image
What Explains Willingness to Pay for Smoking-Cessation Treatments - Addiction Level, Quit-Rate Effectiveness or the Opening Bid?
Olsen, Jan Abel.; Røgeberg, Ole J. Rgeberg; Stavem, Knut - In: Applied Health Economics and Health Policy 10 (2012) 6, pp. 407-415
Background:Background: Several countries have now passed laws that place limitations on where smokers may smoke. A range of smoking-cessation treatments have become available, many of which have documented increased quit rates. Population surveys show that most smokers wish to quit, and most...
Persistent link: https://www.econbiz.de/10011005067